Dibucaine Topical application and Insulin Glargine (U-300) Pens
Determining the interaction of Dibucaine Topical application and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dibucaine topical
Brand name: Dibucaine, Nupercainal, Rectacaine
Synonyms: Dibucaine topical, Dibucaine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dibucaine Topical application-Insulin glargine and lixisenatide
- Dibucaine Topical application-Insulin glargine and lixisenatide Subcutaneous
- Dibucaine Topical application-Insulin glargine, recombinant Subcutaneous
- Dibucaine Topical application-Insulin glulisine
- Dibucaine Topical application-Insulin Glulisine (Cartridges and Pens)
- Dibucaine Topical application-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Dicel
- Insulin Glargine (U-300) Pens-Dichlorphenamide
- Insulin Glargine (U-300) Pens-Diclegis
- Insulin Glargine (U-300) Pens-Diclo Gel
- Insulin Glargine (U-300) Pens-Diclo Gel with Xrylix
- Insulin Glargine (U-300) Pens-Diclofenac